Core Viewpoint - The financing data indicates significant selling pressure on Borui Pharmaceutical, with a net financing sell-out of 220.63 million yuan last week, ranking fourth in the market [1] Financing Activity - Borui Pharmaceutical had a total financing buy amount of 748 million yuan and repayment amount of 969 million yuan last week [1] - Over the past five days, the main capital outflow reached 752 million yuan, with a decline of 13.55% [1] - Over the past ten days, the main capital outflow was 767 million yuan, with a decline of 7.14% [1] Company Profile - Borui Pharmaceutical (Suzhou) Co., Ltd. was established in 2001 and is located in Suzhou, primarily engaged in the pharmaceutical manufacturing industry [1] - The company has a registered capital of 422.465 million yuan and a paid-in capital of 220.624827 million yuan [1] - The legal representative of the company is Yuan Jiandong [1] Investment and Intellectual Property - Borui Pharmaceutical has invested in 38 companies and participated in 50 bidding projects [1] - The company holds 121 trademark registrations and 179 patent registrations, along with 36 administrative licenses [1]

Group 1 - The report tracks stocks, industries, and sectors that are reaching new highs, serving as market indicators and highlighting the effectiveness of momentum and trend-following strategies [1][4][24] - As of August 22, 2025, the Shanghai Composite Index, Shenzhen Component Index, CSI 300, CSI 500, CSI 1000, CSI 2000, ChiNext Index, and Sci-Tech 50 Index all have a distance to their 250-day highs of 0.00%, indicating they are at their recent peaks [5][24] - Among the CITIC first-level industry indices, home appliances, defense and military, comprehensive, media, and computer industries are closest to their 250-day highs, while food and beverage, coal, real estate, banking, and consumer services are further away [8][24] Group 2 - A total of 1,606 stocks reached 250-day highs in the past 20 trading days, with the most significant numbers in the machinery, pharmaceuticals, and electronics sectors [2][13][24] - The highest proportion of new high stocks is found in the defense and military, non-ferrous metals, and pharmaceuticals industries, with respective proportions of 52.94%, 51.61%, and 44.88% [13][16] - The manufacturing and technology sectors have the most stocks reaching new highs this week, with respective counts of 512 and 403 [16][24] Group 3 - The report identifies 48 stocks that have shown stable new highs, with the technology and manufacturing sectors contributing the most, having 22 and 12 stocks respectively [3][21][25] - Within the technology sector, the electronics industry has the highest number of new high stocks, while the automotive industry leads in the manufacturing sector [21][25]

证券之星消息，8月21日化学制药板块较上一交易日上涨0.09%，*ST苏吴领涨。当日上证指数报收于 3771.1，上涨0.13%。深证成指报收于11919.76，下跌0.06%。化学制药板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 600200 | *ST苏吴 | 0.96 | 5.49% | 43.67万 | | 4141.60万 | | 300705 | 九典制药 | 19.87 | 4.97% | 52.35万 | | 10.35 Z | | 300573 | 兴齐眼药 | 67.48 | 4.69% | 22.77万 | | 15.19 Z | | 688506 | 百利天恒 | 324.96 | 4.21% | 1.62万 | | 5.23亿 | | 002940 | 昂利康 | 51.36 | 3.86% | 15.16万 | | 7.69亿 | | 002020 | 京新药业 | 19.52 | 2.90% | 32.05万 | | 6.16 ...

Group 1 - A total of 8 stocks from the Sci-Tech Innovation Board (STAR Market) experienced block trading on August 20, with a cumulative transaction amount of 1.04 billion yuan and a total trading volume of 243.32 million shares [1][2] - The stock with the highest transaction amount was Changying Tong, with a trading volume of 1.22 million shares and a transaction amount of 60.34 million yuan. Other notable stocks included Canxin Technology and Funeng Technology, with transaction amounts of 19.01 million yuan and 8.48 million yuan, respectively [1][2] - All stocks involved in block trading were sold at a discount compared to their closing prices, with the highest discount rates seen in Ailis, Gaoling Information, and Borui Pharmaceutical, at 20.29%, 12.30%, and 9.09% respectively [1][2] Group 2 - In terms of capital flow, four stocks saw net inflows of funds, with Canxin Technology, Daotong Technology, and Borui Pharmaceutical leading with net inflows of 29.08 million yuan, 17.82 million yuan, and 5.44 million yuan, respectively. Conversely, Funeng Technology, Ailis, and Aiwei Technology experienced net outflows of 24.92 million yuan, 21.88 million yuan, and 3.79 million yuan [2] - The average increase for the stocks involved in block trading was 1.44%, with the highest increases recorded for Canxin Technology, Daotong Technology, and Changying Tong, at 7.59%, 1.86%, and 0.71% respectively [1][2]

证券时报·数据宝统计显示，博瑞医药今日收盘价为110.00元，上涨0.36%，日换手率为2.47%，成交额 为11.55亿元，全天主力资金净流入544.02万元，近5日该股累计下跌2.47%，近5日资金合计净流出3.65 亿元。 两融数据显示，该股最新融资余额为22.59亿元，近5日减少3.45亿元，降幅为13.23%。（数据宝） 博瑞医药8月20日大宗交易平台出现一笔成交，成交量3.00万股，成交金额300.00万元，大宗交易成交价 为100.00元，相对今日收盘价折价9.09%。该笔交易的买方营业部为瑞银证券有限责任公司上海花园石 桥路证券营业部，卖方营业部为国投证券股份有限公司江苏分公司。 进一步统计，近3个月内该股累计发生23笔大宗交易，合计成交金额为2.44亿元。 8月20日博瑞医药大宗交易一览 | 成交量 | 成交金额 | 成交价 | 相对当日收盘 | | | | --- | --- | --- | --- | --- | --- | | （万 | （万元） | 格 | 折溢价（%） | 买方营业部 | 卖方营业部 | | 股） | | （元） | | | | | 3.00 | 300.00 | ...

| 2025-08-20 | 博瑞医药 | 688166 | 100 300 | 瑞银证券有限责任 | 国投证券股份有限 | | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | 公司上海花园石桥 | 卖出营业部 公司江苏分公司 | 8月20日，博瑞医药大宗交易成交3万股，成交额300万元，占当日总成交额的0.26%，成交价100元，较市场收盘价110元折价9.09%。 ...

Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board Biopharmaceutical Index decreased by 0.91% as of August 20, 2025, with mixed performance among constituent stocks [1] - Heartbeat Medical led the gains with an increase of 3.13%, while Yuandong Biological experienced the largest decline [1] - The market for the Sci-Tech Medical ETF managed by Harvest saw a turnover rate of 24.05% and a transaction volume of 62.637 million yuan, indicating active trading [3] Group 2 - The latest scale of the Sci-Tech Medical ETF reached 263 million yuan, marking a one-month high and ranking first among comparable funds [3] - The ETF has seen continuous net inflows over the past three days, with a maximum single-day net inflow of 6.157 million yuan, totaling 15.2382 million yuan [3] - The net value of the ETF increased by 56.59% over the past year, with the highest monthly return since inception being 23.29% [3] Group 3 - The total amount of business cooperation for innovative drugs in China is projected to reach 51.9 billion USD in 2024, with a record 1.25 billion USD upfront payment transaction between 3SBio and Pfizer in 2025 [4] - The Chinese innovative drug sector has seen a 25.02% increase year-to-date, ranking fourth among 31 industries, with a current PE ratio of 31.31 times [4] - The National Healthcare Security Administration has introduced a temporary management method for disease-based payment, promoting payment reform in the healthcare sector [4] Group 4 - As of July 31, 2025, the top ten weighted stocks in the Sci-Tech Innovation Board Biopharmaceutical Index accounted for 49.14% of the index, with leading companies including United Imaging and BeiGene [4][6] - The performance of individual stocks varied, with United Imaging down by 0.26% and BeiGene up by 0.95% [6] - Investors without stock accounts can access the Sci-Tech Medical ETF through the Harvest Sci-Tech Medical ETF linked fund [6]

8月19日博瑞医药大宗交易一览 | 成交量 | 成交金额 | 成交价 | 相对当日收盘 | | | | --- | --- | --- | --- | --- | --- | | （万 | （万元） | 格 | 折溢价（%） | 买方营业部 | 卖方营业部 | | 股） | | （元） | | | | | 19.67 | 2155.99 | 109.60 | 0.00 | 中信证券股份有限公司深 | 光大证券股份有限公司北 | | | | | | 圳滨海大道证券营业部 | 京光华路证券营业部 | 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） 博瑞医药8月19日大宗交易平台出现一笔成交，成交量19.67万股，成交金额2155.99万元，大宗交易成交 价为109.60元。该笔交易的买方营业部为中信证券股份有限公司深圳滨海大道证券营业部，卖方营业部 为光大证券股份有限公司北京光华路证券营业部。 进一步统计，近3个月内该股累计发生22笔大宗交易，合计成交金额为2.41亿元。 证券时报·数据宝统计显示，博瑞医药今日收盘价为109.60元，下跌1.97%，日换手率为2.33%，成 ...

8月19日，博瑞医药大宗交易成交19.67万股，成交额2155.99万元，占当日总成交额的1.94%，成交价109.6元，较市场收盘价109.6元持平。 | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( * ) 买入营业部 | | | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | 2025-08-19 | 博瑞医药 | 688166 | 109.6 2155.99 | 19.67 | 中信证券股份有限 | 光大证券股份有限 | | | | | | | 公司深圳滨海大道 | 公司北京光华路证 | | | | | | | 3 mg 246 22 . 11 . 407 | 444 11 . 11 . 447 | ...

11只科创板股大宗交易平台今日发生交易，合计成交1.48亿元。 科创板股8月18日大宗交易概况 证券时报·数据宝统计显示，8月18日共有11只科创板股发生大宗交易，合计成交13笔，累计成交量 254.23万股，成交额合计1.48亿元。 | 代码 | 简称 | 成交笔 | 大宗交易数量 | 平均成交价格 | 相对收盘价折溢价 | 大宗交易金额 | | --- | --- | --- | --- | --- | --- | --- | | | | 数 | （万股） | （元） | （%） | （万元） | | 688692 | 达梦数 | 2 | 15.91 | 234.47 | -6.40 | 3730.47 | | | 据 | | | | | | | 688080 | 映翰通 | 1 | 68.00 | 41.01 | -20.00 | 2788.68 | | 688166 | 博瑞医 药 | 1 | 25.00 | 100.62 | -10.00 | 2515.50 | | 688662 | 富信科 | 2 | 50.00 | 42.32 | | | | | 技 | | | | -13.40 | 2116. ...